Related Experiment Video
Updated: May 8, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
Gut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease
Ji Sook Park1, Ji Hyun Seo, Hee-Shang Youn
1Department of Pediatrics, Gyeongsang National University School of Medicine, Jinju, Korea.
Abstract:
The prevalence of obesity is increasing worldwide. Obesity can cause hyperlipidemia, hypertension, cardiovascular diseases, metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Many environmental or genetic factors have been suggested to contribute to the development of obesity, but there is no satisfactory explanation for its increased prevalence. This review discusses the latest updates on the role of the gut microbiota in obesity and NAFLD.
Related Concept Videos
Functions of the Gut Microbiota
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
Microbiota of the Large Intestine
Gut-Brain Axis
The Oral Microbiota
